Prognostic significance of p21WAF1/CIP1 expression in tongue squamous cell carcinomas

被引:32
|
作者
Xie, X [1 ]
Clausen, OPF
Boysen, M
机构
[1] Univ Oslo, Natl Hosp, Dept Otolaryngol, N-0027 Oslo, Norway
[2] Univ Oslo, Natl Hosp, Inst Pathol, N-0027 Oslo, Norway
关键词
D O I
10.1001/archotol.128.8.897
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
Objective: To investigate the prognostic significance of p21(WAF1/CIP1) expression and its relationship with p53 accumulation and other apoptotic markers such as Bax, Bcl-2, and apoptotic index in relation to disease-specific survival in oral tongue squamous cell carcinoma (SCC). Design: A 10-year retrospective clinical study. Information about clinical findings, treatment, and follow-up has been recorded prospectively. Patients and Methods: Diagnostic, formalin-fixed, paraffin-embedded sections taken from 80 randomly selected patients before treatment for T I to T5 oral tongue SCC were stained immunohistochemically with p21(WAF1/CIP1). The percentages of positive nuclei that stained positive for tumor were determined. Main Outcome Measures: The significance of prognostic parameters was tested by log-rank and Kaplan-Meier methods for the univariate analysis. The Cox proportional hazards regression model was used for multivariate analysis. Results: Expression of p21(WAF1/CIP1) correlated inversely with T classification and clinical stage (P=.02 and P=.006, respectively) but not with N classification, tumor differentiation, or apoptosis-related variables such as p53 accumulation, apoptotic index, and Bax and Bcl-2 expression. Patients with tumor's expressing high p21(WAF1/CIP1) values had increased disease-specific survival time (P=.03). The correlation between p21(WAF1/CIP1) expression and disease-specific survival was even more significant when restricted to p53-negative tumors (P=.002). A 2-parameter combination between p21(WAF1/CIP1) expression and Bax expression or p21(WAF1/CIP1) expression and p53 accumulation, respectively, revealed an enhanced prognostic potential (P<.001) when compared with single parameters. Conclusion: The expression of p21(WAF1/CIP1), particularly in combination with p53 accumulation or Bax expression, has prognostic value in oral tongue SCC.
引用
收藏
页码:897 / 902
页数:6
相关论文
共 50 条
  • [21] Regulation of p21waf1/cip1 expression by intracellular redox conditions
    Esposito, F
    Russo, L
    Chirico, G
    Ammendola, R
    Russo, T
    Cimino, F
    IUBMB LIFE, 2001, 52 (1-2) : 67 - 70
  • [22] p21WAF1/CIP1 protein expression in primary ovarian cancer
    Ferrandina, G
    Stoler, A
    Fagotti, A
    Fanfani, F
    Sacco, R
    De Pasqua, A
    Mancuso, S
    Scambia, G
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2000, 17 (06) : 1231 - 1235
  • [23] Cell cycle arrest and DNA endoreduplication following p21Waf1/Cip1 expression
    Stewart Bates
    Kevin M Ryan
    Andrew C Phillips
    Karen H Vousden
    Oncogene, 1998, 17 : 1691 - 1703
  • [24] Expression and Significance of p21WAF1/CIP1 Gene Protein Product in Human Breast Cancers
    赵春临
    许冰
    吴阳
    梅林
    肿瘤基础与临床, 2000, (06) : 391 - 392
  • [25] Expression of p21WAF1/CIP1 in bladder cancer:: Relation to schistosomiasis
    Eissa, S
    Swelam, M
    Shaker, Y
    Fattah, MA
    Khalifa, A
    IUBMB LIFE, 1999, 48 (01) : 115 - 119
  • [26] p21WAF1/CIP1 and cancer: A shifting paradigm?
    Gartel, Andrei L.
    BIOFACTORS, 2009, 35 (02) : 161 - 164
  • [27] Cell cycle arrest and DNA endoreduplication following p21Waf1/Cip1 expression
    Bates, S
    Ryan, KM
    Phillips, AC
    Vousden, KH
    ONCOGENE, 1998, 17 (13) : 1691 - 1703
  • [28] The clinical significance of p21WAF1/CIP1 protein expression in non-small cell lung cancer
    Dworakowska, Dorota
    WSPOLCZESNA ONKOLOGIA-CONTEMPORARY ONCOLOGY, 2006, 10 (01): : 24 - 27
  • [29] p21WAF1/Cip1:: more than a break to the cell cycle?
    Dotto, GP
    BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2000, 1471 (01): : M43 - M56
  • [30] Clinical significance of p21WAF1/CIP1 and p53 expression in serous cystadenocarcinoma of the ovary
    Terauchi, F
    Okamoto, A
    Nagashima, T
    Kobayashi, Y
    Moritake, T
    Yamamoto, Y
    Takakura, S
    Iwaki, S
    Ogura, H
    ONCOLOGY REPORTS, 2005, 14 (02) : 363 - 368